FDA Says It’s Aware Of Allegations Boston Scientific May Use ‘Counterfeit’ Marlex
“We are examining these allegations to determine any necessary and appropriate next steps,” the FDA said. FDA is not currently aware that the alleged counterfeit raw material contributes to adverse events associated with these products.”
“It is not uncommon for a firm, based on its...
To view the full article, register now.